If at first you don't succeed, let someone else try again. Roche ($RHHBY) is handing over 300 failed drugs to the Broad Institute for screening. New testing methods and screening tools might uncover new uses for the compounds. Report
If at first you don't succeed, let someone else try again. Roche ($RHHBY) is handing over 300 failed drugs to the Broad Institute for screening. New testing methods and screening tools might uncover new uses for the compounds. Report